[Click eStock] "Hubitz, Q4 Last Year Expected to Achieve Record Quarterly Performance"

[Asia Economy Reporter Eunmo Koo] An analysis has emerged that Huvis will achieve its highest quarterly performance in the fourth quarter of last year.

According to Yuanta Securities on the 22nd, Huvis is expected to record sales of 24.7 billion KRW in the fourth quarter of last year, an 11.5% increase compared to the same period last year, and an operating profit of 4 billion KRW, a 145% increase, achieving the highest quarterly performance. Researcher Siwiseop Shim of Yuanta Securities stated in a report on the same day, "Along with the seasonal peak effect and benefits from continued market growth, strong sales of optometry devices overall are expected, accompanied by a significant improvement in profit margins."

This year, steady growth is expected to continue with stable sales growth, the effect of renewed new products, and new business sales generation. Researcher Shim said, "The headquarters plans to launch four new products in the second half of the year, and the subsidiary Shanghai Huvis is also scheduled to release five new products in the third quarter," adding, "Despite the third quarter being a seasonal off-season, growth compared to the previous quarter is expected due to the new product effect, and steady sales growth is anticipated every quarter starting from the first quarter, which is the off-season."

Huvis is a specialized ophthalmic medical device company listed on the KOSDAQ market in 2003. It holds the top position domestically and ranks third globally in the optometry device market, maintaining a high status in the market. In a highly competitive market, it continues steady growth exceeding market growth rates through cost competitiveness, technological competitiveness, sales networks, and references. Exports account for 85% on a separate basis, and sales by product are composed of 69% optometry-related devices, 21% ophthalmic diagnostic devices, and 10% others. Additionally, it owns subsidiaries Shanghai Huvis (67% stake) and HS Partners, established to target the Chinese market.

This content was produced with the assistance of AI translation services.